Education
About Us
Working with TipRanks
Follow Us
Osteopore Ltd. (AU:OSX)
ASX:OSX
OSX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.05
Previous CloseN/A
Volume70.28K
Average Volume (3M)4.39M
Market Cap
AU$2.61M
Enterprise ValueAU$4.78M
Total Cash (Recent Filing)AU$638.50K
Total Debt (Recent Filing)AU$1.33M
Price to Earnings (P/E)―
Beta4.32
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding237,259,980
10 Day Avg. Volume4,948,994
30 Day Avg. Volume4,385,335
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
Osteopore Ltd. News
OSX FAQ
What was Osteopore Ltd.’s price range in the past 12 months?
Osteopore Ltd. lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is Osteopore Ltd.’s market cap?
Osteopore Ltd.’s market cap is AU$2.61M.
When is Osteopore Ltd.’s upcoming earnings report date?
Osteopore Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 19 days.
How were Osteopore Ltd.’s earnings last quarter?
Currently, no data Available
Is Osteopore Ltd. overvalued?
According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued.
Does Osteopore Ltd. pay dividends?
Osteopore Ltd. does not currently pay dividends.
What is Osteopore Ltd.’s EPS estimate?
Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Osteopore Ltd. have?
Osteopore Ltd. has 237,259,980 shares outstanding.
What happened to Osteopore Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Osteopore Ltd.?
Currently, no hedge funds are holding shares in AU:OSX
Osteopore Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Neutral
AU:OSX Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.80%
12-Months-Change
Fundamentals
Return on Equity
-907.51%
Trailing 12-Months
Asset Growth
-6.23%
Trailing 12-Months
Company Description
Osteopore Ltd.
Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.
Osteopore Ltd. (OSX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Orthocell Ltd
―
Aroa Biosurgery Ltd
―
ImExHS Limited
―
Emyria Ltd
―
Arovella Therapeutics Limited
―
Ownership Overview
0.94% Insiders
―
Mutual Funds
― Other Institutional Investors
99.06% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---